Roflumilast for the treatment of diabetes mellitus type 2

US8541456B2 · kind B2 · utility

Assignee

• TAKEDA GMBH · DE

Inventors

• Hans-Peter Kley · Allensbach, DE
• Guido Hanauer · Konstanz, DE
• Daniela Hauser · Singen, DE
• Beate Schmidt · Allensbach, DE
• Dirk Bredenbröker · Konstanz, DE
• Wilhelm Wurst · Konstanz, DE
• Jörg Kemkowski · Hamburg, DE

Key dates

• Filing date: Jul 11, 2011
• Grant date: Sep 24, 2013
• Expiry date: Jul 11, 2031

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The application relates to specific combinations of Roflumilast and/or Roflumilast N-Oxide and a PPAR-agonist, as well as their use in the treatment of diabetes mellitus type 2.